HK1168795A1 - Assays for influenza virus hemagglutinins - Google Patents

Assays for influenza virus hemagglutinins

Info

Publication number
HK1168795A1
HK1168795A1 HK12109646.5A HK12109646A HK1168795A1 HK 1168795 A1 HK1168795 A1 HK 1168795A1 HK 12109646 A HK12109646 A HK 12109646A HK 1168795 A1 HK1168795 A1 HK 1168795A1
Authority
HK
Hong Kong
Prior art keywords
assays
influenza virus
virus hemagglutinins
hemagglutinins
influenza
Prior art date
Application number
HK12109646.5A
Other languages
English (en)
Chinese (zh)
Inventor
Philip Dormitzer
Yingxia Wen
Gene Palmer
Paola Rinella
Ping Wu
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK1168795A1 publication Critical patent/HK1168795A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/11—Orthomyxoviridae, e.g. influenza virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151—Methods of production or purification of viral material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/11—Orthomyxoviridae, e.g. influenza virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
HK12109646.5A 2009-05-29 2012-09-28 Assays for influenza virus hemagglutinins HK1168795A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21740509P 2009-05-29 2009-05-29
PCT/IB2010/001423 WO2010136896A1 (en) 2009-05-29 2010-05-28 Assays for influenza virus hemagglutinins

Publications (1)

Publication Number Publication Date
HK1168795A1 true HK1168795A1 (en) 2013-01-11

Family

ID=42542829

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12109646.5A HK1168795A1 (en) 2009-05-29 2012-09-28 Assays for influenza virus hemagglutinins

Country Status (11)

Country Link
US (1) US20120237545A1 (de)
EP (1) EP2435066B1 (de)
JP (2) JP5823379B2 (de)
KR (1) KR20120030442A (de)
CN (1) CN103764160A (de)
AU (1) AU2010252661B2 (de)
CA (1) CA2763440A1 (de)
EA (1) EA201171491A1 (de)
HK (1) HK1168795A1 (de)
NZ (1) NZ596671A (de)
WO (1) WO2010136896A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013088367A1 (en) 2011-12-12 2013-06-20 Novartis Ag Assay for influenza virus hemagglutinins
WO2014054712A1 (ja) * 2012-10-05 2014-04-10 デンカ生研株式会社 インフルエンザウイルスのヘムアグルチニンの測定方法
US10596100B2 (en) 2012-12-19 2020-03-24 L'oreal Cosmetic compositions containing an alkoxysilane and a silsesquioxane resin
MX2015015428A (es) * 2013-05-10 2016-07-18 Novartis Ag Eliminacion de riesgo de narcolepsia en vacunas contra influenza.
KR102576962B1 (ko) 2015-07-07 2023-09-11 세퀴러스 유케이 리미티드 인플루엔자 효능 검정
KR102546626B1 (ko) * 2020-04-29 2023-06-21 에스케이바이오사이언스(주) 인플루엔자 바이러스 항원 정제 조건 신속 확인 시험
BR112022021921A2 (pt) * 2020-04-29 2022-12-13 Sk Bioscience Co Ltd Método de produção do vírus influenza com o uso de sistema de processo de cultura de uso único e teste de confirmação rápida da condição de purificação de antígeno do vírus influenza

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0832638B2 (ja) 1989-05-25 1996-03-29 カイロン コーポレイション サブミクロン油滴乳剤を含んで成るアジュバント製剤
US5762939A (en) 1993-09-13 1998-06-09 Mg-Pmc, Llc Method for producing influenza hemagglutinin multivalent vaccines using baculovirus
AU5543294A (en) 1993-10-29 1995-05-22 Pharmos Corp. Submicron emulsions as vaccine adjuvants
AU1308495A (en) 1994-01-11 1995-08-01 Rijksuniversiteit Gent Influenza vaccine
FR2723740B1 (fr) * 1994-08-16 1996-11-08 Pasteur Merieux Serums Vacc Procede de preparation d'antigenes du virus grippal, antigenes obtenus et leurs applications
DE19612966B4 (de) 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
AU7126998A (en) 1997-04-16 1998-11-11 Connaught Laboratories Inc. Anti-influenza compositions supplemented with neuraminidase
US6080725A (en) 1997-05-20 2000-06-27 Galenica Pharmaceuticals, Inc. Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof
GB9923176D0 (en) 1999-09-30 1999-12-01 Smithkline Beecham Biolog Novel composition
EP1405862B1 (de) * 2002-10-02 2008-04-09 F.Hoffmann-La Roche Ag Verfahren zur Identifizierung antigener Peptide
CA2514667C (en) * 2003-01-30 2013-01-08 Chiron Corporation Adjuvanted influenza vaccine
CA2560185C (en) * 2004-03-17 2013-05-07 Crucell Holland B.V. Novel assay for the separation and quantification of hemagglutinin antigens
EP1742659B1 (de) 2004-04-05 2013-03-13 Pah Usa 15 Llc Mikrofluidisierte öl-in-wasser-emulsionen und vakzinezusammensetzungen
US7691368B2 (en) 2005-04-15 2010-04-06 Merial Limited Vaccine formulations
US8703095B2 (en) 2005-07-07 2014-04-22 Sanofi Pasteur S.A. Immuno-adjuvant emulsion
JP2009502789A (ja) * 2005-07-19 2009-01-29 ダウ グローバル テクノロジーズ インコーポレイティド 組み換えインフルエンザワクチン
WO2008001221A2 (en) 2006-06-21 2008-01-03 Novartis Ag Concurrent delivery device for multiple vaccines
EP3456348A1 (de) 2006-09-11 2019-03-20 Seqirus UK Limited Herstellung von influenza-virus-impfstoffen ohne verwendung von eiern

Also Published As

Publication number Publication date
WO2010136896A1 (en) 2010-12-02
CA2763440A1 (en) 2010-12-02
US20120237545A1 (en) 2012-09-20
AU2010252661B2 (en) 2013-08-22
JP5823379B2 (ja) 2015-11-25
JP2012528139A (ja) 2012-11-12
AU2010252661A1 (en) 2011-12-22
JP2015098479A (ja) 2015-05-28
EP2435066A1 (de) 2012-04-04
EA201171491A1 (ru) 2012-07-30
NZ596671A (en) 2013-06-28
EP2435066B1 (de) 2013-11-20
KR20120030442A (ko) 2012-03-28
CN103764160A (zh) 2014-04-30

Similar Documents

Publication Publication Date Title
IL239023A0 (en) Neutralizing antibodies to influenza virus
GB201115214D0 (en) Influenza virus antibody compositions
SG11201402780UA (en) Influenza a virus specific antibodies
HK1170495A1 (en) Tri- or tetraspecific antibodies
ES2451507T8 (es) Brida de fijación
EP2663334A4 (de) Antikörper gegen influenza
ZA201009273B (en) Monoclonal antibodies having homosubtype cross-neutralization properties against influenza a viruses subtype h1
DE102009037898A8 (de) Greifeinrichtung
EP2768858A4 (de) Antikörper gegen influenza
EP2118323A4 (de) Erkennung des influenza-virus
GB0822068D0 (en) Methods for virus design
EP2309264A4 (de) Grippevirusnachweisvorrichtung
SI2427576T1 (sl) Generični testi za odkrivanje virusov influence
GB0807424D0 (en) Virus
HK1168795A1 (en) Assays for influenza virus hemagglutinins
EP2780445A4 (de) Verformbare plattformen für biologische assays
HK1202924A1 (zh) 用於流感病毒血凝素的測定
EP2596347A4 (de) Lab-on-chip zur alkalitätsanalyse
BR112012003591A2 (pt) conjunto de recipientes
GB2484349B (en) Sinusoidal flange
EP2486054A4 (de) Rekombinante antikörper gegen h1n1-influenza
GB0918679D0 (en) Influenza vaccine
HK1171961A1 (en) Prophylactic composition for influenza infection
EP2435476A4 (de) Aus vögeln gewonnene antikörper
EP2627788A4 (de) Assays auf mikrovesikelbasis

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180528